Cargando…

The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019

OBJECTIVE. To assess the demographics, risk profiles and outcome indicators of one of the few government-supported programs on pre-exposure prophylaxis (PrEP) in the English-speaking Caribbean. METHODS. Chart review of all persons enrolled into the national PrEP Program from its inception on March 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Best, Anton, Rambarran, Nastassia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Organización Panamericana de la Salud 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064290/
https://www.ncbi.nlm.nih.gov/pubmed/33907558
http://dx.doi.org/10.26633/RPSP.2021.51
_version_ 1783682103056007168
author Best, Anton
Rambarran, Nastassia
author_facet Best, Anton
Rambarran, Nastassia
author_sort Best, Anton
collection PubMed
description OBJECTIVE. To assess the demographics, risk profiles and outcome indicators of one of the few government-supported programs on pre-exposure prophylaxis (PrEP) in the English-speaking Caribbean. METHODS. Chart review of all persons enrolled into the national PrEP Program from its inception on March 1(st) 2018 to November 30(th) 2019, with a descriptive summary analysis of the data extracted. RESULTS. Of the 134 persons enrolled into the program most identified as men who have sex with men (67.9%), followed by men who have sex with men and women (14.9%); there were 20 persons, mostly men (85%), in sero-discordant relationships. PrEP uptake was 96%; however, the continuation rate (continuing for three consecutive months after initiation) was 61.5%. Continuation status for many could not be ascertained due to loss-to-follow-up. PrEP-associated toxicity prevalence was 2.3%, although side-effects occurred in 52% (mostly gastrointestinal). HIV positivity during the study period was 1.5%. CONCLUSIONS. Uptake of Barbados’ national PrEP Program is excellent but fairly low continuation rates and the HIV positivity rate indicate the need for improved pre-ART initiation education and follow-up processes. Service utilisation is mainly by men who have sex with men, and provision expansion to other civil society partners and private practitioners, as well as increased public awareness could increase access by other high-risk groups.
format Online
Article
Text
id pubmed-8064290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Organización Panamericana de la Salud
record_format MEDLINE/PubMed
spelling pubmed-80642902021-04-26 The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019 Best, Anton Rambarran, Nastassia Rev Panam Salud Publica Original Research OBJECTIVE. To assess the demographics, risk profiles and outcome indicators of one of the few government-supported programs on pre-exposure prophylaxis (PrEP) in the English-speaking Caribbean. METHODS. Chart review of all persons enrolled into the national PrEP Program from its inception on March 1(st) 2018 to November 30(th) 2019, with a descriptive summary analysis of the data extracted. RESULTS. Of the 134 persons enrolled into the program most identified as men who have sex with men (67.9%), followed by men who have sex with men and women (14.9%); there were 20 persons, mostly men (85%), in sero-discordant relationships. PrEP uptake was 96%; however, the continuation rate (continuing for three consecutive months after initiation) was 61.5%. Continuation status for many could not be ascertained due to loss-to-follow-up. PrEP-associated toxicity prevalence was 2.3%, although side-effects occurred in 52% (mostly gastrointestinal). HIV positivity during the study period was 1.5%. CONCLUSIONS. Uptake of Barbados’ national PrEP Program is excellent but fairly low continuation rates and the HIV positivity rate indicate the need for improved pre-ART initiation education and follow-up processes. Service utilisation is mainly by men who have sex with men, and provision expansion to other civil society partners and private practitioners, as well as increased public awareness could increase access by other high-risk groups. Organización Panamericana de la Salud 2021-04-23 /pmc/articles/PMC8064290/ /pubmed/33907558 http://dx.doi.org/10.26633/RPSP.2021.51 Text en https://creativecommons.org/licenses/by/2.5/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 IGO License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. No modifications or commercial use of this article are permitted. In any reproduction of this article there should not be any suggestion that PAHO or this article endorse any specific organization or products. The use of the PAHO logo is not permitted. This notice should be preserved along with the article’s original URL. Open access logo and text by PLoS, under the Creative Commons Attribution-Share Alike 3.0 Unported license.
spellingShingle Original Research
Best, Anton
Rambarran, Nastassia
The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019
title The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019
title_full The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019
title_fullStr The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019
title_full_unstemmed The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019
title_short The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019
title_sort demographic features and outcome indicators of the barbados hiv pre-exposure prophylaxis program, 2018-2019
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064290/
https://www.ncbi.nlm.nih.gov/pubmed/33907558
http://dx.doi.org/10.26633/RPSP.2021.51
work_keys_str_mv AT bestanton thedemographicfeaturesandoutcomeindicatorsofthebarbadoshivpreexposureprophylaxisprogram20182019
AT rambarrannastassia thedemographicfeaturesandoutcomeindicatorsofthebarbadoshivpreexposureprophylaxisprogram20182019
AT bestanton demographicfeaturesandoutcomeindicatorsofthebarbadoshivpreexposureprophylaxisprogram20182019
AT rambarrannastassia demographicfeaturesandoutcomeindicatorsofthebarbadoshivpreexposureprophylaxisprogram20182019